ESTERO, FL / ACCESS Newswire / December 4, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) (“Aspire” or the “Company”), ...

ESTERO, FLORIDA / ACCESS Newswire / December 2, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) (“Aspire” or the ...

Pharmacokinetic and pharmacodynamic data of Anaphylm sublingual epinephrine film in pediatric patients were similar to data reported in adults, according to phase 1 study results.This study on ...

In a milestone moment for chronic pain management, Tonix Pharmaceuticals announced on August 15, 2025, that its novel ...

Emerging markets with improved healthcare infrastructure and supportive reimbursement policies are accelerating access to solutions. The integration of telemedicine and digital health technologies ...

The transmucosal drug delivery systems market is poised for growth due to its noninvasive methods, rapid action, and high bioavailability. This system is ideal for chronic disease management, ...

Aspire Biopharma (ASBP) announced that on November 3, 2025, it submitted its Pre-IND meeting request and briefing package to the U.S. Food and ...

VANCOUVER, BC / ACCESS Newswire / December 9, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is advancing the development of a next-generation "Melt in Your ...

Arthritis, a condition that causes joints to become inflamed, painful, and less mobile, affects around 54.4 million Americans ...

In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine ...

Alpha Cognition Inc. ( ACOG) Discusses Commercial Adoption Metrics and Market Opportunity in Long-Term Care December 2, 2025 12:00 PM EST ...

Mycosis fungoides, the most prevalent CTCL subtype, accounts for the majority of cases. Although early-stage disease has a five-year survival rate of roughly 88%, it is a chronic cancer with ...